col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


51 Results       Page 1

 [1] 
Springer-Verlag: The European Journal of Health Economics
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2026―Aug―26 Understanding moral trade-offs in pandemic response: A discrete choice experiment on avian influenza policies Nicholas V. R. Smeele, Charlotte N. M. Waltz, Anja J. M. Schreijer, Pearl A. Dykstra
2 [GO] 2026―Apr―24 Paid and unpaid productivity losses across 28 European countries due to excess deaths and COVID-19 deaths from 2020 to 2023 Paweł Niewiadomski, Marta Ortega-Ortega, Błażej Łyszczarz
3 [GO] 2026―Apr―06 Public preferences for saving lives versus life-years: evidence from a person-trade-off experiment in 12 countries during the COVID-19 pandemic Fiorella Parra-Mujica, Laurence S. J. Roope, Mara Violato, Raymond M. Duch, Philip M. Clarke
4 [GO] 2026―Mar―21 Non-communicable diseases, COVID-19 and labour market outcomes Wasana Kalansooriya, Victoria Serra-Sastre, Mireia Jofre-Bonet
5 [GO] 2026―Jan―21 Assessing the costs and benefits of non-pharmaceutical pandemic measures using the economic values of social contacts Mortaza Baky Haskuee, Ali Asgary, Zachary McCarthy, Sperydon Koumarianos, Callista Wu, Ali Parsa, Andrew Fallone, Jianhong Wu
6 [GO] 2026―Jan―12 The effect of age-specific stay-at-home recommendation on healthcare utilization: Evidence from Finland’s COVID-19 policy Jukka Laaksonen, Mika Kortelainen, Henri Salokangas
7 [GO] 2025―Jul―10 Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland Joseph Kwon, Joseph Mensah, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Johannes De Kock, Manoj Sivan, Stavros Petrou
8 [GO] 2025―Jun―14 Time preferences and COVID-19 vaccination uptake Arthur E. Attema, Marcello Antonini, Mesfin Genie, Aleksandra Torbica, Francesco Paolucci
9 [GO] 2024―Jul―27 Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19 Wenjing Zhou, Yaqin Li, Jan Busschbach, Michael Herdman, Zhihao Yang, Yanming Lu
10 [GO] 2024―Mar―18 From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands Iris Meulman, Ellen Uiters, Mariëlle Cloin, Jeroen Struijs, Johan Polder, Niek Stadhouders
11 [GO] 2024―Feb―29 Can redistribution of vaccine improve global welfare? Lessons from COVID-19 Gunjan Kumari, Oindrila Dey
12 [GO] 2023―Dec―26 Impact of Long COVID on productivity and informal caregiving Joseph Kwon, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Jordan Mullard, Ghazala Mir, Brendan Delaney, Manoj Sivan, Stavros Petrou
13 [GO] 2023―Oct―21 Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic Sebastian Himmler, Job van Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, Tom Stargardt, Pedro Pita Barros, Aleksandra Torbica
14 [GO] 2023―Jul―06 Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic Sebastian Himmler, Job van Exel, Werner Brouwer, Sebastian Neuman-Böhme, Iryna Sabat, Jonas Schreyögg, Tom Stargardt, Pedro Pita Barros, Aleksandra Torbica
15 [GO] 2023―Jun―17 COVID-19 and income inequality in OECD countries: a methodological comment-a reply John Wildman
16 [GO] 2023―Feb―23 COVID-19 and EQ-5D-5L health state valuation Edward J. D. Webb, Paul Kind, David Meads, Adam Martin
17 [GO] 2023―Feb―20 Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France Julien Bergeot, Florence Jusot
18 [GO] 2023―Feb―02 The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions Alvaro Almeida
19 [GO] 2023―Jan―19 Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany Hoa Thi Nguyen, Claudia M. Denkinger, Stephan Brenner, Lisa Koeppel, Lucia Brugnara, Robin Burk, Michael Knop, Till Bärnighausen, Andreas Deckert, Manuela De Allegri
20 [GO] 2022―Aug―11 Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic Yi Wang, Nantasit Luangasanatip, Wirichada Pan-ngum, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Sompob Saralamba, Christopher Painter, Jamaica Roanne Briones, Yot Teerawattananon
21 [GO] 2022―Aug―02 Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown Jose Robles-Zurita
22 [GO] 2022―Jul―24 Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands Paul Mark Mitchell, Rachael L. Morton, Mickaël Hiligsmann, Samantha Husbands, Joanna Coast
23 [GO] 2022―Apr―25 Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic Jacques Bughin, Michele Cincera, Evelyn Kiepfer, Dorota Reykowska, Florian Philippi, Marcin Żyszkiewicz, Rafal Ohme, Dirk Frank
24 [GO] 2022―Mar―19 The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies Florian Dorn, Sahamoddin Khailaie, Marc Stoeckli, Sebastian C. Binder, Tanmay Mitra, Berit Lange, Stefan Lautenbacher, Andreas Peichl, Patrizio Vanella, Timo Wollmershäuser, Clemens Fuest, Michael Meyer-Hermann
25 [GO] 2022―Mar―19 Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment Jonathan Sicsic, Serge Blondel, Sandra Chyderiotis, François Langot, Judith E. Mueller
26 [GO] 2022―Mar―09 Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities Ignacio Amate-Fortes, Almudena Guarnido-Rueda
27 [GO] 2022―Feb―16 Communities and testing for COVID-19 Steven Stillman, Mirco Tonin
28 [GO] 2022―Feb―09 Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics Axel C. Mühlbacher, Andrew Sadler, Yvonne Jordan
29 [GO] 2022―Jan―11 COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach Matthias Klumpp, Dominic Loske, Silvio Bicciato
30 [GO] 2021―Nov―19 Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme Danny Wende, Dagmar Hertle, Claudia Schulte, Pedro Ballesteros, Uwe Repschläger
31 [GO] 2021―Nov―11 The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes Eline Moens, Louis Lippens, Philippe Sterkens, Johannes Weytjens, Stijn Baert
32 [GO] 2021―Nov―09 Microeconomics of intertemporal choice in zero-space during Covid-19: a behavioral economics perspective Javier Cifuentes-Faura, Renaud Di Francesco
33 [GO] 2021―Nov―06 Work ethics, stay-at-home measures and COVID-19 diffusion Vincenzo Alfano
34 [GO] 2021―Oct―22 Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan Eyal Lahav, Shosh Shahrabani, Mosi Rosenboim, Yoshiro Tsutsui
35 [GO] 2021―Aug―21 The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study Paul Hanly, Michelle Ahern, Linda Sharp, Diana Ursul, Gerard Loughnane
36 [GO] 2021―Aug―04 Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy Gaetano Perone
37 [GO] 2021―Jul―25 Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis Amit Summan, Arindam Nandi
38 [GO] 2021―Jul―20 Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe? Sebastian Himmler, Job van Exel, Werner Brouwer
39 [GO] 2021―Jul―15 How the COVID-19 pandemic can distort risk adjustment of health plan payment Richard C. van Kleef, Mieke Reuser
40 [GO] 2021―Jul―13 COVID-19: not the time for health economists? A plea for more proactive health economic involvement J.-Matthias Graf von der Schulenburg
41 [GO] 2021―Jul―08 The impact of COVID-19 pandemic on insurance demand: the case of China Xianhang Qian
42 [GO] 2021―Jul―05 Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests Juan Del Llano, Jorge Mestre-Ferrandiz, Jaime Espin, Jordi Gol-Montserrat, Alicia del Llano, Carlos Bringas
43 [GO] 2021―May―06 Assessing the consequences of quarantines during a pandemic Rikard Forslid, Mathias Herzing
44 [GO] 2021―May―03 Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections Donatella Saccone
45 [GO] 2021―Mar―22 Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe Mounir Amdaoud, Giuseppe Arcuri, Nadine Levratto
46 [GO] 2021―Feb―18 COVID-19 and income inequality in OECD countries John Wildman
47 [GO] 2021―Jan―02 COVID-19 and the role of inequality in French regional departments Victor Ginsburgh, Glenn Magerman, Ilaria Natali
48 [GO] 2020―Nov―24 More room for telemedicine after COVID-19: lessons for primary care? Livio Garattini, Marco Badinella Martini, Michele Zanetti
49 [GO] 2020―Jun―26 Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 Sebastian Neumann-Böhme, Nirosha Elsem Varghese, Iryna Sabat, Pedro Pita Barros, Werner Brouwer, Job van Exel, Jonas Schreyögg, Tom Stargardt
50 [GO] 2020―Jun―04 Historical evidence for economic effects of COVID-19 Rahmiye Figen Ceylan, Burhan Ozkan, Esra Mulazimogullari
51 [GO] 2020―Jun―03 Modelling Covid-19 under uncertainty: what can we expect? Meimei Wang, Steffen Flessa
 [1] 

51 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec